Abstract
Background: Numerous serology assays are available for detection of SARS-CoV-2 antibodies but are limited in that only 1 or 2 target antigen(s) can be tested at a time. Here, we describe a novel multiplex assay that simultaneously detects and quantifies IgG antibodies to SARS-CoV-2 antigens, spike (S), nucleocapsid (N), receptor-binding domain (RBD), and N-terminal domain (NTD) in a single well.
Methods: Sensitivity was determined using samples (n = 124) from confirmed SARS-CoV-2 RT-PCR positive individuals. Prepandemic (n = 100) and non-COVID respiratory infection positive samples (n = 100) were used to evaluate specificity. Samples were analyzed using COVID-19 IgG multiplex serology assay from Meso Scale Discovery (MSD) and using commercial platforms from Abbott, EUROIMMUN, and Siemens.
Results: At >14 days post-PCR, MSD assay displayed >98.0% sensitivity [S 100% (95% CI 98.0%-100.0%); N 98.0% (95% CI 97.2%-98.9%); RBD 94.1% (95% CI 92.6%-95.6%); NTD 98.0% (95% CI, 97.2%-98.9%)] and 99% specificity (95% CI 99.3%-99.7%) for antibodies to all 4 antigens. Parallel assessment of antibodies to more than 1 antigen improved the sensitivity to 100% (95% CI 98.0%-100.0%) while maintaining 98% (95% CI 97.6%-98.4%) specificity regardless of the combinations used. When AU/mL concentrations of IgG antibodies from the MSD assay were compared against the corresponding IgG signals acquired from the single target commercial assays, the following correlations were observed: Abbott (vs MSD N, R2 = 0.73), Siemens (vs MSD RBD, R2 = 0.92), and EUROIMMUN (vs MSD S, R2 = 0.82).
Conclusion: MSD assay offers an accurate and a comprehensive assessment of SARS-CoV-2 antibodies with higher sensitivity and equivalent specificity compared to the commercial IgG serology assays.
Keywords: immunology; infectious disease; microbiology; multiplex immunoassays.
【저자키워드】 immunology, Microbiology, Infectious disease, multiplex immunoassays., 【초록키워드】 COVID-19, immunology, IgG, Microbiology, antibody, Infectious disease, Antigen, immunoassays, sensitivity, specificity, respiratory infection, SARS-CoV-2 antibodies, IgG antibody, Multiplex assay, Receptor-binding domain, SARS-CoV-2 antibody, IgG antibodies, nucleocapsid, multiplex serology, RBD, antigens, NTD, SARS-CoV-2 RT-PCR, respiratory, multiplex, correlation, Euroimmun, platform, SARS-CoV-2 antigens, N-terminal domain, Combination, Concentration, Abbott, 95% CI, domain, combinations, serology assays, positive individuals, Siemens, offer, positive sample, Meso Scale Discovery, tested, analyzed, detect, Sample, evaluate, assays, was determined, were used, Numerous, MSD, serology assay, Siemen, 【제목키워드】 SARS-CoV-2, IgG, detection, novel, Simultaneous, Against,